Nintedanib esylate is an organosulfonate salt obtained by combining nintedanib with one molar equivalent of ethanesulfonic acid. A kinase inhibitor used for the treatment of idiopathic pulmonary fibrosis and cancer. Among its listed roles, it functions as a angiogenesis inhibitor, an antineoplastic agent, a fibroblast growth factor receptor antagonist, a tyrosine kinase inhibitor and a vascular endothelial growth factor receptor antagonist. It includes a nintedanib. It is grouped under the following drug class(es): Tyrosine Kinase Inhibitors and VEGF inhibitors. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Nintedanib ethanesulfonate and Nintedanib Ethanesulfonate Salt. Its PubChem CID is 135476717.
Nintedanib esylate
| CAS No | 656247-18-6 |
|---|---|
| Molecular Formula | C33H39N5O7S |
| Molecular Weight | 649.8 g/mol |
| Synonyms | ethanesulfonic acid;methyl 2-hydroxy-3-[N-[4-[methyl-[2-(4-methylpiperazin-1-yl)acetyl]amino]phenyl]-C-phenylcarbonimidoyl]-1H-indole-6-carboxylate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Nintedanib esylate is an organosulfonate salt obtained by combining nintedanib with one molar equivalent of ethanesulfonic acid. A kinase inhibitor used for the treatment of idiopathic pulmonary fibrosis and cancer.
The listed CAS number is 656247-18-6.
The listed molecular formula is C33H39N5O7S.
The listed molecular weight is 649.8 g/mol.
ethanesulfonic acid;methyl 2-hydroxy-3-[N-[4-[methyl-[2-(4-methylpiperazin-1-yl)acetyl]amino]phenyl]-C-phenylcarbonimidoyl]-1H-indole-6-carboxylate.
The source lists Nintedanib ethanesulfonate and Nintedanib Ethanesulfonate Salt.